TRANSFAC FACTOR TABLE, Release 2017.2 - public - 2017-06-30, (C) QIAGEN

AC T00950 XX ID T00950 XX DT 23.06.1993 (created); ewi. DT 27.01.2015 (updated); spk. CO Copyright (C), QIAGEN. XX FA IkappaB-alpha XX SY human inhibitor kappaB-alpha; I-kappa-B-alpha; IkappaB-alpha; IKBA; MAD-3; MAD3; NF-kappa-B inhibitor alpha; NFKBI; NFKBIA. XX OS human, Homo sapiens OC eukaryota; animalia; metazoa; chordata; vertebrata; tetrapoda; mammalia; eutheria; primates XX GE G002981 NFKBIA; HGNC: NFKBIA. XX CL C0020; Rel; XX SF ankyrin repeats interact with, e. g., c-Rel, but the PEST sequence is responsible for inhibition of DNA-binding [20]; XX CP (monocytes). XX FF S-Adenosylmethionine (SAMe) treatment decreases the protein expression in HepG2 cells [70]; FF Pretreatment of THP-1 cells with V5 tagged human ST2 induces the degradation of IkappaB-alpha following the LPS stimulation [53]; FF inhibits NF-kappaB (not c-Rel or v-Rel) through the RelA (p65) subunit [11] [4] [1]; FF masking of the nuclear localization signals of both the RelA and the NF-kappaB1 (p50) subunit [7] [22]; FF retains NF-kappaB in the cytoplasm, but also may dissociate it from the DNA [1]; FF zeta-PKC binds to and activates a 50-kDa IkappaB kinase [17]; FF dsRNA-activates p68 protein kinase (PKR) directly phosphorylates IkappaB-alpha and activates NF-kappaB [26]; FF one upstream kinase is Raf-1 [23]; FF external triggers of IkappaB phosphorylation and inactivation are TNF-alpha or IL-1 [14]; FF phosphorylation and rapid proteolytic degradation triggered by HTLV-I Tax [13]; FF phosphorylated IkappaB-alpha still binds to NF-kappaB but is tagged for rapid degradation by a chymotrypsin-like activity of the proteasome [18]; FF in B cells, constitutive phosphorylation of IkappaB-alpha may contribute to constitutive NF-kappaB activity in these cells [9]; FF in other cells, IkappaB is subjected to a constant low-level turnover providing a very low concentration of active NF-kappaB [25]; FF in addition to IkappaB phosphorylation, a dephosphorylation step is also required for IkappaB inactivation which is mediated by the calcium-calmodulin-dependent protein phosphatase calcineurin [15]; FF TNF signalling to activate NF-kappaB by IkappaB degradation involves sphingomyelinase [16]; FF expression of the IkappaB-alpha gene is enhanced by NF-kappaB [6] [12] [22] [24] [25]; FF also, glucocorticoids induce IkappaB synthesis and thus decrease the concentration of active NF-kappaB [21] [27]; FF IkappaB-alpha is rapidly induced following monocyte adherence due to a posttranscriptional control mechanism [19] [2]; FF enhanced cAMP levels may cause a retarded degradation of IkappaB-alpha in T cells [10]; XX IN T02765 ERR1; human, Homo sapiens. IN T04106 HDAC1; human, Homo sapiens. IN T04110 HDAC3; human, Homo sapiens. IN T01924 NF-kappaB1-isoform1; mouse, Mus musculus. IN T00593 NF-kappaB1-p50; human, Homo sapiens. IN T01925 NF-kappaB1; human, Homo sapiens. IN T00587 NF-kappaB; rat, Rattus norvegicus. IN T00588 NF-kappaB; mouse, Mus musculus. IN T00590 NF-kappaB; human, Homo sapiens. IN T21984 p300; human, Homo sapiens. IN T00594 RelA-p65-isoform1; human, Homo sapiens. IN T00595 RelA-p65; mouse, Mus musculus. IN T08711 RelA-p65; human, Homo sapiens. IN T10397 RelA-p65; Mammalia. IN T00897 v-Rel; REV-T, reticuloendotheliosis virus (strain T). XX DR TRANSPATH: MO000019315. DR UniProtKB: P25963; XX RN [1]; RE0000091. RX PUBMED: 2184941. RA Zabel U., Bauerle P. A. RT Purified human IkappaB can rapidly dissociate the complex of the NF-kappaB transcription factor with its cognate DNA RL Cell 61:255-265 (1990). RN [2]; RE0000240. RX PUBMED: 1829648. RA Haskill S., Beg A. A., Tompkins S. M., Morris J. S., Yurochko A. D., Sampson-Johannes A., Mondal K., Ralph P., Baldwin jr A. S. RT Characterization of an immediate-early gene induced in adherent monocytes that encodes IkappaB-like activity RL Cell 65:1281-1289 (1991). RN [3]; RE0000458. RX PUBMED: 2050119. RA Urban M. B., Schreck R., Baeuerle P. A. RT NF-kappaB contacts DNA by a heterodimer of the p50 and p65 subunit RL EMBO J. 10:1817-1825 (1991). RN [4]; RE0000726. RX PUBMED: 2125960. RA Urban M. B., Baeuerle P. A. RT The 65-kD subunit of NF-kappaB is a receptor for IkappaB and a modulator of DNA-binding specificity RL Genes Dev. 4:1975-1984 (1990). RN [5]; RE0001807. RX PUBMED: 2157987. RA Ghosh S., Baltimore D. RT Activation in vitro of NF-kappaB by phosphorylation of its inhibitor IkappaB RL Nature 344:678-682 (1990). RN [6]; RE0004482. RX PUBMED: 8262046. RA Bail O. L., Schmidt-Ullrich R., Israel A. RT Promoter analysis of the gene encoding the IkappaB-alpha/MAD3 inhibitor of NF-kappaB: positive regulation by members of the rel/NF-kappaB family RL EMBO J. 12:5043-5049 (1993). RN [7]; RE0004487. RX PUBMED: 7679069. RA Zabel U., Henkel T., dos Santos Silva M., Baeuerle P. A. RT Nuclear uptake control of NF-kappaB by MAD-3, an IkappB protein present in the nucleus RL EMBO J. 12:201-211 (1993). RN [8]; RE0004503. RX PUBMED: 7651415. RA Stein B., Yang M. X. RT Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappaB and C/EBPbeta RL Mol. Cell. Biol. 15:4971-4979 (1995). RN [9]; RE0004507. RX PUBMED: 7925300. RA Naumann M., Scheidereit C. RT Activation of NF-6B in vivo is regulated by multiple phosphorylations RL EMBO J. 13:4597-4607 (1994). RN [10]; RE0004548. RX PUBMED: 7744006. RA Neumann M., Grieshammer T., Chuvpilo S., Kneitz B., Lohoff M., Schimpl A., Franza jr B. R., Serfling E. RT ReIA/p65 is a molecular target for the immunosuppressive action of protein kinase A RL EMBO J. 14:1991-2004 (1995). RN [11]; RE0004549. RX PUBMED: 1340770. RA Beg A. A., Ruben S. M., Scheinman R. I., Rosen C. A., Baldwin jr A. S. RT IkappaB interacts with the nuclear localization sequences of the subunits of the NF-kappaB: a mechanism for cytoplasmic retention RL Genes Dev. 6:1899-1913 (1992). RN [12]; RE0004551. RX PUBMED: 8319912. RA Scott M. L., Fujita T., Liou H.-C., Nolan G. P., Baltimore D. RT The p65 subunit of NF-kappaB regulates IkappaB by two distinct mechanisms RL Genes Dev. 7:1266-1276 (1993). RN [13]; RE0004565. RX PUBMED: 7935451. RA Sun S.-C., Elwood J., Beraud C., Greene W. C. RT Human T-cell leukemia virus type I Tax activation of NF-kappaB/Rel involves phosphorylation and degradation of IkappaBalpha and RelA (p65)-mediated induction of the c-rel gene RL Mol. Cell. Biol. 14:7377-7384 (1994). RN [14]; RE0004591. RX PUBMED: 8497253. RA Beg A. A., Finco T. S., Nantermet P. V., Baldwin jr A. S. RT Tumor necrosis factor and interleukin-1 lead to phosphorylation and loss of IkappaBalpha: a mechanism for NF-kappaB activation RL Mol. Cell. Biol. 13:3301-3310 (1993). RN [15]; RE0004593. RX PUBMED: 8112299. RA Frantz B., Nordby E. C., Bren G., Steffan N., Paya C. V., Kincaid R. L., Tocci M. J., O'Keefe S. J., O'Neill E. A. RT Calcineurin acts in synergy with PMA to inactivate IkappaB/MAD3, an inhibitor of NF-kappaB RL EMBO J. 13:861-870 (1994). RN [16]; RE0004594. RX PUBMED: 8188652. RA Machleidt T., Wiegmann K., Henkel T., Schuetze S., Baeuerle P., Kroenke M. RT Sphingomyelinase activates proteolytic IkappaB-alpha degradation in a cell-free system RL J. Biol. Chem. 269:13760-13765 (1994). RN [17]; RE0004595. RX PUBMED: 8026469. RA Diaz-Meco M. T., Dominguez I., Sanz L., Dent P., Lozano J., Municio M. M., Berra E., Hay R. T., Sturgill T. W., Moscat J. RT ZetaPKC induces phosphorylation and inactivation of IkappaB-alpha in vitro RL EMBO J. 13:2842-2848 (1994). RN [18]; RE0004596. RX PUBMED: 7957109. RA Traenckner E. B.-M., Wilk S., Baeuerle P. A. RT A proteasome inhibitor prevents activation of NF-kappaB and stabilizes a newly phosphorylated form of IkappaB-alpha that is still bound to NF-kappaB RL EMBO J. 13:5433-5441 (1994). RN [19]; RE0004600. RX PUBMED: 7532282. RA Lofquist A. K., Mondal K., Morris J. S., Haskill J. S. RT Transcription-independent turnover of IkappaBalpha during monocyte adherence: implications for a translational component regulating IkappaBalpha/MAD-3 mRNA levels RL Mol. Cell. Biol. 15:1737-1746 (1995). RN [20]; RE0004601. RX PUBMED: 7823953. RA Ernst M. K., Dunn L. L., Rice N. R. RT The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmatic retention of c-Rel or RelA homodimers RL Mol. Cell. Biol. 15:872-882 (1995). RN [21]; RE0004602. RX PUBMED: 7569975. RA Scheinman R. I., Cogswell P. C., Lofquist A. K., Baldwin jr A. S. RT Role of transcriptional activation of IkappaBalpha in mediation of immunosuppression of glucocorticoids RL Science 270:283-286 (1995). RN [22]; RE0004606. RX PUBMED: 8096091. RA Sun S.-C., Ganchi P. A., Ballard D. W., Greene W. C. RT NF-kappaB controls expression of inhibitor IkappaBalpha: Evidence for an inducible autoregulatory pathway RL Science 259:1912-1915 (1993). RN [23]; RE0004607. RX PUBMED: 8415686. RA Li S., Sedivy J. M. RT Raf-1 protein kinase activates the NF-kappaB transcription factor by dissociating the cytoplasmic NF-kappaB-IkappaB complex RL Proc. Natl. Acad. Sci. USA 90:9247-9251 (1993). RN [24]; RE0004608. RX PUBMED: 8460169. RA Brown K., Park S., Kanno T., Franzoso G., Siebenlist U. RT Mutual regulation of the transcriptional activator NF-kappaB and its inhibitor, IkappaBalpha RL Proc. Natl. Acad. Sci. USA 90:2532-2536 (1993). RN [25]; RE0004609. RX PUBMED: 8223478. RA Rice N. R., Ernst M. K. RT In vivo control of NF-kappaB activation by IkappaBalpha RL EMBO J. 12:4685-4695 (1993). RN [26]; RE0004611. RX PUBMED: 7912826. RA Kumar A., Haque J., Lacoste J., Hiscott J., Williams B. R. G. RT Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappaB by phosphorylating IkappaB RL Proc. Natl. Acad. Sci. USA 91:6288-6292 (1994). RN [27]; RE0004639. RX PUBMED: 7569976. RA Auphan N., Didonato J. A., Rosette C., Helmberg A., Karin M. RT Imunosuppression by glucocorticoids: Inhibition of NF-6B activity through induction of I6B synthesis RL Science 270:286-290 (1995). RN [28]; RE0013471. RX PUBMED: 9135156. RA Whiteside S. T., Epinat J. C., Rice N. R., Israel A. RT I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. RL EMBO J. 16:1413-1426 (1997). RN [29]; RE0022005. RX PUBMED: 11865184. RA Rothwarf D. M., Karin M. RT The NF-kappaB activation pathway: a paradigm in information transfer from membrane to nucleus RL Sci. STKE 26: (1999). RN [30]; RE0030766. RX PUBMED: 12482991. RA Lang V., Janzen J., Fischer G. Z., Soneji Y., Beinke S., Salmeron A., Allen H., Hay R. T., Ben-Neriah Y., Ley S. C. RT betaTrCP-mediated proteolysis of NF-kappaB1 p105 requires phosphorylation of p105 serines 927 and 932. RL Mol. Cell. Biol. 23:402-13 (2003). RN [31]; RE0031419. RX PUBMED: 12972430. RA Viatour P., Legrand-Poels S., van Lint C., Warnier M., Merville M. P., Gielen J., Piette J., Bours V., Chariot A. RT Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. RL J. Biol. Chem. 278:46541-8 (2003). RN [32]; RE0032702. RX PUBMED: 12419817. RA Jiang X., Takahashi N., Matsui N., Tetsuka T., Okamoto T. RT The NF-kappa B activation in lymphotoxin beta receptor signaling depends on the phosphorylation of p65 at serine 536. RL J. Biol. Chem. 278:919-26 (2003). RN [33]; RE0033324. RX PUBMED: 14976190. RA Catley M. C., Cambridge L. M., Nasuhara Y., Ito K., Chivers J. E., Beaton A., Holden N. S., Bergmann M. W., Barnes P. J., Newton R. RT Inhibitors of protein kinase C (PKC) prevent activated transcription: role of events downstream of NF-kappaB DNA binding. RL J. Biol. Chem. 279:18457-66 (2004). RN [34]; RE0034755. RX PUBMED: 11960379. RA Bhat-Nakshatri P., Sweeney C. J., Nakshatri H. RT Identification of signal transduction pathways involved in constitutive NF-kappaB activation in breast cancer cells. RL Oncogene 21:2066-78 (2002). RN [35]; RE0047426. RX PUBMED: 15677444. RA Fagerlund R., Kinnunen L., Kohler M., Julkunen I., Melen K. RT NF-{kappa}B is transported into the nucleus by importin {alpha}3 and importin {alpha}4. RL J. Biol. Chem. 280:15942-15951 (2005). RN [36]; RE0047668. RX PUBMED: 15465828. RA Buss H., Dorrie A., Schmitz M. L., Frank R., Livingstone M., Resch K., Kracht M. RT Phosphorylation of serine 468 by GSK-3beta negatively regulates basal p65 NF-kappaB activity. RL J. Biol. Chem. 279:49571-49574 (2004). RN [37]; RE0047741. RX PUBMED: 9624136. RA Boland M. P., O'Neill L. A. RT Ceramide activates NFkappaB by inducing the processing of p105. RL J. Biol. Chem. 273:15494-15500 (1998). RN [38]; RE0047815. RX PUBMED: 9576928. RA Deak J. C., Cross J. V., Lewis M., Qian Y., Parrott L. A., Distelhorst C. W., Templeton D. J. RT Fas-induced proteolytic activation and intracellular redistribution of the stress-signaling kinase MEKK1. RL Proc. Natl. Acad. Sci. USA 95:5595-5600 (1998). RN [39]; RE0047959. RX PUBMED: 16547522. RA Wu C. J., Conze D. B., Li T., Srinivasula S. M., Ashwell J. D. RT Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation. RL Nat. Cell Biol. 8:398-406 (2006). RN [40]; RE0049538. RX PUBMED: 12909638. RA Waris G., Livolsi A., Imbert V., Peyron J. F., Siddiqui A. RT Hepatitis C virus NS5A and subgenomic replicon activate NF-kappaB via tyrosine phosphorylation of IkappaBalpha and its degradation by calpain protease. RL J. Biol. Chem. 278:40778-40787 (2003). RN [41]; RE0049614. RX PUBMED: 15710892. RA Foy E., Li K., Sumpter R J. r., Loo Y. M., Johnson C. L., Wang C., Fish P. M., Yoneyama M., Fujita T., Lemon S. M., Gale M J. r. RT Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling. RL Proc. Natl. Acad. Sci. USA 102:2986-2991 (2005). RN [42]; RE0050028. RX PUBMED: 14690596. RA Ryo A., Suizu F., Yoshida Y., Perrem K., Liou Y. C., Wulf G., Rottapel R., Yamaoka S., Lu K. P. RT Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. RL Mol. Cell 12:1413-1426 (2003). RN [43]; RE0050192. RX PUBMED: 15592525. RA Jun J. I., Chung C. W., Lee H. J., Pyo J. O., Lee K. N., Kim N. S., Kim Y. S., Yoo H. S., Lee T. H., Kim E., Jung Y. K. RT Role of FLASH in caspase-8-mediated activation of NF-kappaB: dominant-negative function of FLASH mutant in NF-kappaB signaling pathway. RL Oncogene 24:688-696 (2005). RN [44]; RE0051083. RX PUBMED: 17483331. RA Ostrander J. H., Daniel A. R., Lofgren K., Kleer C. G., Lange C. A. RT Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. RL Cancer Res. 67:4199-4209 (2007). RN [45]; RE0051415. RX PUBMED: 10669746. RA Castrillo A., Diaz-Guerra M. J., Hortelano S., Martin-Sanz P., Bosca L. RT Inhibition of IkappaB kinase and IkappaB phosphorylation by 15-deoxy-Delta(12,14)-prostaglandin J(2) in activated murine macrophages. RL Mol. Cell. Biol. 20:1692-1698 (2000). RN [46]; RE0051581. RX PUBMED: 17932028. RA Doyle S. L., Jefferies C. A., Feighery C., O'Neill L. A. RT Signaling by Toll-like Receptors 8 and 9 Requires Bruton's Tyrosine Kinase. RL J. Biol. Chem. 282:36953-36960 (2007). RN [47]; RE0051619. RX PUBMED: 15951441. RA Hu W. H., Pendergast J. S., Mo X. M., Brambilla R., Bracchi-Ricard V., Li F., Walters W. M., Blits B., He L., Schaal S. M., Bethea J. R. RT NIBP, a novel NIK and IKK(beta)-binding protein that enhances NF-(kappa)B activation. RL J. Biol. Chem. 280:29233-29241 (2005). RN [48]; RE0051641. RX PUBMED: 15208311. RA Hu W. H., Mo X. M., Walters W. M., Brambilla R., Bethea J. R. RT TNAP, a novel repressor of NF-kappaB-inducing kinase, suppresses NF-kappaB activation. RL J. Biol. Chem. 279:35975-35983 (2004). RN [49]; RE0051660. RX PUBMED: 16046471. RA Schwabe R. F., Sakurai H. RT IKKbeta phosphorylates p65 at S468 in transactivaton domain 2. RL FASEB J. 19:1758-1760 (2005). RN [50]; RE0051693. RX PUBMED: 18037881. RA Ahmad R., Raina D., Trivedi V., Ren J., Rajabi H., Kharbanda S., Kufe D. RT MUC1 oncoprotein activates the IkappaB kinase beta complex and constitutive NF-kappaB signalling. RL Nat. Cell Biol. 9:1419-1427 (2007). RN [51]; RE0051899. RX PUBMED: 18056395. RA Lakshmanan U., Porter A. G. RT Caspase-4 interacts with TNF receptor-associated factor 6 and mediates lipopolysaccharide-induced NF-kappaB-dependent production of IL-8 and CC chemokine ligand 4 (macrophage-inflammatory protein-1 ). RL J. Immunol. 179:8480-8490 (2007). RN [52]; RE0051930. RX PUBMED: 17644309. RA Yamaguchi T., Miki Y., Yoshida K. RT Protein kinase C delta activates IkappaB-kinase alpha to induce the p53 tumor suppressor in response to oxidative stress. RL Cell. Signal. 19:2088-2097 (2007). RN [53]; RE0052208. RX PUBMED: 16426569. RA Takezako N., hayakawa M., Hayakawa H., Aoki S., Yanagisawa K., Endo H., Tominaga S. RT ST2 suppresses IL-6 production via the inhibition of IkappaB degradation induced by the LPS signal in THP-1 cells. RL Biochem. Biophys. Res. Commun. 341:425-432 (2006). RN [54]; RE0052768. RX PUBMED: 18070880. RA Piao W., Song C., Chen H., Wahl L. M., Fitzgerald K. A., O'Neill L. A., Medvedev A. E. RT Tyrosine phosphorylation of MyD88 adapter-like (Mal) is critical for signal transduction and blocked in endotoxin tolerance. RL J. Biol. Chem. 283:3109-3119 (2008). RN [55]; RE0053154. RX PUBMED: 17991436. RA Hochrainer K., Racchumi G., Anrather J. RT Hypo-phosphorylation leads to nuclear retention of NF-kappaB p65 due to impaired IkappaBalpha gene synthesis. RL FEBS Lett. 581:5493-5499 (2007). RN [56]; RE0053206. RX PUBMED: 17183367. RA Maine G. N., Mao X., Komarck C. M., Burstein E. RT COMMD1 promotes the ubiquitination of NF-kappaB subunits through a cullin-containing ubiquitin ligase. RL EMBO J. 26:436-447 (2007). RN [57]; RE0053307. RX PUBMED: 16230348. RA Yoshida H., Jono H., Kai H., Li J. D. RT The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. RL J. Biol. Chem. 280:41111-41121 (2005). RN [58]; RE0053491. RX PUBMED: 16415872. RA Mansell A., Smith R., Doyle S. L., Gray P., Fenner J. E., Crack P. J., Nicholson S. E., Hilton D. J., O'Neill L. A., Hertzog P. J. RT Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. RL Nat. Immunol. 7:148-155 (2006). RN [59]; RE0053529. RX PUBMED: 10655476. RA Huang T. T., Kudo N., Yoshida M., Miyamoto S. RT A nuclear export signal in the N-terminal regulatory domain of IkappaBalpha controls cytoplasmic localization of inactive NF-kappaB/IkappaBalpha complexes. RL Proc. Natl. Acad. Sci. USA 97:1014-1019 (2000). RN [60]; RE0053543. RX PUBMED: 10940917. RA Mattner J., Schindler H., Diefenbach A., Rollinghoff M., Gresser I., Bogdan C. RT Regulation of type 2 nitric oxide synthase by type 1 interferons in macrophages infected with Leishmania major. RL Eur. J. Immunol. 30:2257-2267 (2000). RN [61]; RE0053645. RX PUBMED: 18045535. RA Wan F., Anderson D. E., Barnitz R. A., Snow A., Bidere N., Zheng L., Hegde V., Lam L. T., Staudt L. M., Levens D., Deutsch W. A., Lenardo M. J. RT Ribosomal protein S3: a KH domain subunit in NF-kappaB complexes that mediates selective gene regulation. RL Cell 131:927-939 (2007). RN [62]; RE0053839. RX PUBMED: 16407239. RA Mattioli I., Geng H., Sebald A., Hodel M., Bucher C., Kracht M., Schmitz M. L. RT Inducible phosphorylation of NF-kappa B p65 at serine 468 by T cell costimulation is mediated by IKK epsilon. RL J. Biol. Chem. 281:6175-6183 (2006). RN [63]; RE0053853. RX PUBMED: 18515365. RA Cahill C. M., Rogers J. T. RT Interleukin-1beta induction of IL-6 is mediated by a novel phosphatidylinositol 3-kinase dependent AKT/Ikappa B kinase alpha pathway targeting activator protein-1. RL J. Biol. Chem. 283:25900-25912 (2008). RN [64]; RE0053894. RX PUBMED: 17307160. RA Lin C. C., Chiang L. L., Lin C. H., Shih C. H., Liao Y. T., Hsu M. J., Chen B. C. RT Transforming growth factor-beta1 stimulates heme oxygenase-1 expression via the PI3K/Akt and NF-kappaB pathways in human lung epithelial cells. RL Eur. J. Pharmacol. 560:101-109 (2007). RN [65]; RE0054072. RX PUBMED: 11687592. RA Solan N. J., Miyoshi H., Carmona E. M., Bren G. D., Paya C. V. RT RelB cellular regulation and transcriptional activity are regulated by p100. RL J. Biol. Chem. 277:1405-1418 (2002). RN [66]; RE0054112. RX PUBMED: 18687905. RA Aneja R. K., Tsung A., Sjodin H., Gefter J. V., Delude R. L., Billiar T. R., Fink M. P. RT Preconditioning with high mobility group box 1 (HMGB1) induces lipopolysaccharide (LPS) tolerance. RL J. Leukoc. Biol. 84:1326-1334 (2008). RN [67]; RE0054190. RX PUBMED: 12820969. RA Saccani S., Pantano S., Natoli G. RT Modulation of NF-kappaB activity by exchange of dimers. RL Mol. Cell 11:1563-1574 (2003). RN [68]; RE0054420. RX PUBMED: 18436431. RA Holden N. S., Squires P. E., Kaur M., Bland R., Jones C. E., Newton R. RT Phorbol ester-stimulated NF-kappaB-dependent transcription: roles for isoforms of novel protein kinase C. RL Cell. Signal. 20:1338-1348 (2008). RN [69]; RE0054529. RX PUBMED: 17785851. RA Liu G., Tsuruta Y., Gao Z., Park Y. J., Abraham E. RT Variant IL-1 receptor-associated kinase-1 mediates increased NF-kappa B activity. RL J. Immunol. 179:4125-4134 (2007). RN [70]; RE0054532. RX PUBMED: 17591973. RA Qiu W., Zhou B., Chu P. G., Luh F., Yen Y. RT The induction of growth arrest DNA damage-inducible gene 45 beta in human hepatoma cell lines by S-adenosylmethionine. RL Am. J. Pathol. 171:287-296 (2007). RN [71]; RE0054543. RX PUBMED: 17317104. RA Jamaluddin M., Wang S., Boldogh I., Tian B., Brasier A. R. RT TNF-alpha-induced NF-kappaB/RelA Ser(276) phosphorylation and enhanceosome formation is mediated by an ROS-dependent PKAc pathway. RL Cell. Signal. 19:1419-1433 (2007). RN [72]; RE0054588. RX PUBMED: 17548605. RA Mandrekar P., Jeliazkova V., Catalano D., Szabo G. RT Acute alcohol exposure exerts anti-inflammatory effects by inhibiting IkappaB kinase activity and p65 phosphorylation in human monocytes. RL J. Immunol. 178:7686-7693 (2007). RN [73]; RE0054862. RX PUBMED: 17728246. RA Hinz M., Broemer M., Arslan S. C., Otto A., Mueller E. C., Dettmer R., Scheidereit C. RT Signal responsiveness of IkappaB kinases is determined by Cdc37-assisted transient interaction with Hsp90. RL J. Biol. Chem. 282:32311-32319 (2007). RN [74]; RE0055178. RX PUBMED: 18362169. RA Nowak D. E., Tian B., Jamaluddin M., Boldogh I., Vergara L. A., Choudhary S., Brasier A. R. RT RelA Ser276 phosphorylation is required for activation of a subset of NF-kappaB-dependent genes by recruiting cyclin-dependent kinase 9/cyclin T1 complexes. RL Mol. Cell. Biol. 28:3623-3638 (2008). RN [75]; RE0055271. RX PUBMED: 17068485. RA Lebre M. C., van der Aar A. M., van Baarsen L., van Capel T. M., Schuitemaker J. H., Kapsenberg M. L., de Jong E. C. RT Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. RL J. Invest. Dermatol 127:331-341 (2007). RN [76]; RE0055314. RX PUBMED: 18794297. RA Fraczek J., Kim T. W., Xiao H., Yao J., Wen Q., Li Y., Casanova J. L., Pryjma J., Li X. RT The kinase activity of IL-1 receptor-associated kinase 4 is required for interleukin-1 receptor/toll-like receptor-induced TAK1-dependent NFkappaB activation. RL J. Biol. Chem. 283:31697-31705 (2008). RN [77]; RE0055337. RX PUBMED: 17311279. RA Liang K. C., Lee C. W., Lin W. N., Lin C. C., Wu C. B., Luo S. F., Yang C. M. RT Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells. RL J. Cell. Physiol. 211:759-770 (2007). RN [78]; RE0055339. RX PUBMED: 18336852. RA Lin C. C., Tseng H. W., Hsieh H. L., Lee C. W., Wu C. Y., Cheng C. Y., Yang C. M. RT Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells. RL Toxicol. Appl. Pharmacol. 229:386-398 (2008). RN [79]; RE0055629. RX PUBMED: 17941827. RA Yang C., Klein E. A., Assoian R. K., Kazanietz M. G. RT Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1. RL Biochem. J. 410:167-175 (2008). RN [80]; RE0055924. RX PUBMED: 17347143. RA Lavrik I. N., Golks A., Riess D., Bentele M., Eils R., Krammer P. H. RT Analysis of CD95 threshold signaling: triggering of CD95 (FAS/APO-1) at low concentrations primarily results in survival signaling. RL J. Biol. Chem. 282:13664-13671 (2007). RN [81]; RE0060871. RX PUBMED: 16737960. RA Qin J., Yao J., Cui G., Xiao H., Kim T. W., Fraczek J., Wightman P., Sato S., Akira S., Puel A., Casanova J. L., Su B., Li X. RT TLR8-mediated NF-kappaB and JNK activation are TAK1-independent and MEKK3-dependent. RL J. Biol. Chem. 281:21013-21021 (2006). RN [82]; RE0060983. RX PUBMED: 16920985. RA Lin C. H., Cheng H. W., Hsu M. J., Chen M. C., Lin C. C., Chen B. C. RT c-Src mediates thrombin-induced NF-kappaB activation and IL-8/CXCL8 expression in lung epithelial cells. RL J. Immunol. 177:3427-3438 (2006). RN [83]; RE0063150. RX PUBMED: 19026643. RA Liu X. Y., Seh C. C., Cheung P. C. RT HSP90 is required for TAK1 stability but not for its activation in the pro-inflammatory signaling pathway. RL FEBS Lett. 582:4023-4031 (2008). RN [84]; RE0063354. RX PUBMED: 11723253. RA Chen C. C., Chiu K. T., Chan S. T., Chern J. W. RT Conjugated polyhydroxybenzene derivatives block tumor necrosis factor-alpha-mediated nuclear factor-kappaB activation and cyclooxygenase-2 gene transcription by targeting IkappaB kinase activity. RL Mol. Pharmacol. 60:1439-1448 (2001). RN [85]; RE0063495. RX PUBMED: 17085432. RA Clarke C. J., Truong T. G., Hannun Y. A. RT Role for neutral sphingomyelinase-2 in tumor necrosis factor alpha-stimulated expression of vascular cell adhesion molecule-1 (VCAM) and intercellular adhesion molecule-1 (ICAM) in lung epithelial cells: p38 MAPK is an upstream regulator of nSMase2. RL J. Biol. Chem. 282:1384-1396 (2007). RN [86]; RE0063550. RX PUBMED: 18292573. RA Madge L. A., Kluger M. S., Orange J. S., May M. J. RT Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells. RL J. Immunol. 180:3467-3477 (2008). RN [87]; RE0063965. RX PUBMED: 18694960. RA Moschonas A., Kouraki M., Knox P. G., Thymiakou E., Kardassis D., Eliopoulos A. G. RT CD40 induces antigen transporter and immunoproteasome gene expression in carcinomas via the coordinated action of NF-kappaB and of NF-kappaB-mediated de novo synthesis of IRF-1. RL Mol. Cell. Biol. 28:6208-6222 (2008). RN [88]; RE0063985. RX PUBMED: 19472212. RA Qi X. F., Kim D. H., Yoon Y. S., Jin D., Huang X. Z., Li J. H., Deung Y. K., Lee K. J. RT Essential involvement of cross-talk between IFN-gamma and TNF-alpha in CXCL10 production in human THP-1 monocytes. RL J. Cell. Physiol. 220:690-697 (2009). RN [89]; RE0064195. RX PUBMED: 16318585. RA Ganster R. W., Guo Z., Shao L., Geller D. A. RT Differential effects of TNF-alpha and IFN-gamma on gene transcription mediated by NF-kappaB-Stat1 interactions. RL J. Interferon Cytokine Res. 25:707-719 (2005). RN [90]; RE0064780. RX PUBMED: 17728252. RA Marron M. B., Singh H., Tahir T. A., Kavumkal J., Kim H. Z., Koh G. Y., Brindle N. P. RT Regulated proteolytic processing of Tie1 modulates ligand responsiveness of the receptor-tyrosine kinase Tie2. RL J. Biol. Chem. 282:30509-30517 (2007). RN [91]; RE0064813. RX PUBMED: 18621737. RA Varfolomeev E., Goncharov T., Fedorova A. V., Dynek J. N., Zobel K., Deshayes K., Fairbrother W. J., Vucic D. RT c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. RL J. Biol. Chem. 283:24295-24299 (2008). RN [92]; RE0064946. RX PUBMED: 18955562. RA Pecaric-Petkovic T., Didichenko S. A., Kaempfer S., Spiegl N., Dahinden C. A. RT Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. RL Blood 113:1526-1534 (2009). RN [93]; RE0064965. RX PUBMED: 12702497. RA Yu Y., Zeng H., Lyons S., Carlson A., Merlin D., Neish A. S., Gewirtz A. T. RT TLR5-mediated activation of p38 MAPK regulates epithelial IL-8 expression via posttranscriptional mechanism. RL Am. J. Physiol. Gastrointest. Liver Physiol. 285:G282-90 (2003). RN [94]; RE0064982. RX PUBMED: 18559343. RA Erridge C., Kennedy S., Spickett C. M., Webb D. J. RT Oxidized phospholipid inhibition of toll-like receptor (TLR) signaling is restricted to TLR2 and TLR4: roles for CD14, LPS-binding protein, and MD2 as targets for specificity of inhibition. RL J. Biol. Chem. 283:24748-24759 (2008). RN [95]; RE0065066. RX PUBMED: 18362142. RA Kao C. Y., Kim C., Huang F., Wu R. RT Requirements for two proximal NF-kappaB binding sites and IkappaB-zeta in IL-17A-induced human beta-defensin 2 expression by conducting airway epithelium. RL J. Biol. Chem. 283:15309-15318 (2008). RN [96]; RE0065080. RX PUBMED: 19527497. RA Yanagisawa S., Koarai A., Sugiura H., Ichikawa T., Kanda M., Tanaka R., Akamatsu K., Hirano T., Matsunaga K., Minakata Y., Ichinose M. RT Oxidative stress augments toll-like receptor 8 mediated neutrophilic responses in healthy subjects. RL Respir. Res. 10:50 (2009). RN [97]; RE0065096. RX PUBMED: 18180283. RA Windheim M., Stafford M., Peggie M., Cohen P. RT Interleukin-1 (IL-1) induces the Lys63-linked polyubiquitination of IL-1 receptor-associated kinase 1 to facilitate NEMO binding and the activation of IkappaBalpha kinase. RL Mol. Cell. Biol. 28:1783-1791 (2008). RN [98]; RE0065287. RX PUBMED: 19820695. RA Lamb A., Yang X. D., Tsang Y. H., Li J. D., Higashi H., Hatakeyama M., Peek R. M., Blanke S. R., Chen L. F. RT Helicobacter pylori CagA activates NF-kappaB by targeting TAK1 for TRAF6-mediated Lys 63 ubiquitination. RL EMBO Rep. 10:1242-1249 (2009). RN [99]; RE0065544. RX PUBMED: 19940113. RA Zhang X., Shephard F., Kim H. B., Palmer I. R., McHarg S., Fowler G. J., O'Neill L. A., Kiss-Toth E., Qwarnstrom E. E. RT TILRR, a novel IL-1RI co-receptor, potentiates MYD88-recruitment to control ras-dependent amplification of NF-kappaB. RL J. Biol. Chem. 285:7222-7232 (2009). RN [100]; RE0065728. RX PUBMED: 19131965. RA Shembade N., Parvatiyar K., Harhaj N. S., Harhaj E. W. RT The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling. RL EMBO J. 28:513-522 (2009). RN [101]; RE0065967. RX PUBMED: 18408758. RA Chen R., Alvero A. B., Silasi D. A., Kelly M. G., Fest S., Visintin I., Leiser A., Schwartz P. E., Rutherford T., Mor G. RT Regulation of IKKbeta by miR-199a affects NF-kappaB activity in ovarian cancer cells. RL Oncogene 27:4712-4723 (2008). RN [102]; RE0066377. RX PUBMED: 12107827. RA Nickoloff B. J., Qin J. Z., Chaturvedi V., Denning M. F., Bonish B., Miele L. RT Jagged-1 mediated activation of notch signaling induces complete maturation of human keratinocytes through NF-kappaB and PPARgamma. RL Cell Death Differ. 9:842-855 (2002). RN [103]; RE0066556. RX PUBMED: 17522703. RA Kim N. H., Jeon S., Lee H. J., Lee A. Y. RT Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes. RL J. Invest. Dermatol 127:2612-2617 (2007). RN [104]; RE0066728. RX PUBMED: 19656324. RA Garcin G., Le Gallic L., Stoebner P. E., Guezennec A., Guesnet J., Lavabre-Bertrand T., Martinez J., Meunier L. RT Constitutive expression of MC1R in HaCaT keratinocytes inhibits basal and UVB-induced TNF-alpha production. RL Photochem. Photobiol. 85:1440-1450 (2009). RN [105]; RE0067372. RX PUBMED: 20538615. RA Bi L., Gorjestani S., Wu W., Hsu Y. M., Zhu J., Ariizumi K., Lin X. RT CARD9 mediates Dectin-2-induced IKK ubiquitination leading to activation of NF-kappaB in response to the stimulation by the hyphal form of Candida albicans. RL J. Biol. Chem. 285:25969-25977 (2010). RN [106]; RE0067571. RX PUBMED: 19323897. RA Li M., Liu Z. H., Chen Q., Zhou W. Q., Yu M. W., Lu G. X., Lu X. L., Shen Y. N., Liu W. D., Wu S. X. RT Insoluble beta-glucan from the cell wall of Candida albicans induces immune responses of human THP-1 monocytes through Dectin-1. RL Chin. Med. J. 122:496-501 (2009). RN [107]; RE0067904. RX PUBMED: 19533666. RA Cho S. G., Li D., Stafford L. J., Luo J., Rodriguez-Villanueva M., Wang Y., Liu M. RT KiSS1 suppresses TNFalpha-induced breast cancer cell invasion via an inhibition of RhoA-mediated NF-kappaB activation. RL J. Cell. Biochem. 107:1139-1149 (2009). RN [108]; RE0067949. RX PUBMED: 19357230. RA Decker Y., McBean G., Godson C. RT Lipoxin A4 inhibits IL-1beta-induced IL-8 and ICAM-1 expression in 1321N1 human astrocytoma cells. RL Am. J. Physiol. Cell Physiol. 296:C1420-7 (2009). RN [109]; RE0067981. RX PUBMED: 18678662. RA Snoeks L., Weber C. R., Turner J. R., Bhattacharyya M., Wasland K., Savkovic S. D. RT Tumor suppressor Foxo3a is involved in the regulation of lipopolysaccharide-induced interleukin-8 in intestinal HT-29 cells. RL Infect. Immun. 76:4677-4685 (2008). RN [110]; RE0068049. RX PUBMED: 19956541. RA Chhikara M., Wang S., Kern S. J., Ferreyra G. A., Barb J. J., Munson P. J., Danner R. L. RT Carbon monoxide blocks lipopolysaccharide-induced gene expression by interfering with proximal TLR4 to NF-kappaB signal transduction in human monocytes. RL PLoS ONE 4:e8139 (2009). RN [111]; RE0068196. RX PUBMED: 20195469. RA Gao N., Kumar A., Jyot J., Yu F. S. RT Flagellin-induced corneal antimicrobial peptide production and wound repair involve a novel NF-kappaB-independent and EGFR-dependent pathway. RL PLoS ONE 5:e9351 (2010). RN [112]; RE0069403. RX PUBMED: 17936701. RA Yang H., Minamishima Y. A., Yan Q., Schlisio S., Ebert B. L., Zhang X., Zhang L., Kim W. Y., Olumi A. F., Kaelin WG J. r. RT pVHL acts as an adaptor to promote the inhibitory phosphorylation of the NF-kappaB agonist Card9 by CK2. RL Mol. Cell 28:15-27 (2007). RN [113]; RE0069949. RX PUBMED: 16513645. RA Totzke G., Essmann F., Pohlmann S., Lindenblatt C., Janicke R. U., Schulze-Osthoff K. RT A novel member of the IkappaB family, human IkappaB-zeta, inhibits transactivation of p65 and its DNA binding. RL J. Biol. Chem. 281:12645-12654 (2006). RN [114]; RE0070125. RX PUBMED: 20484576. RA Zhang W., Wang J., Zhang Y., Yuan Y., Guan W., Jin C., Chen H., Wang X., Yang X., He F. RT The scaffold protein TANK/I-TRAF inhibits NF-kappaB activation by recruiting polo-like kinase 1. RL Mol. Biol. Cell 21:2500-2513 (2010). RN [115]; RE0070131. RX PUBMED: 20696840. RA Culver C., Sundqvist A., Mudie S., Melvin A., Xirodimas D., Rocha S. RT Mechanism of hypoxia-induced NF-kappaB. RL Mol. Cell. Biol. 30:4901-4921 (2010). RN [116]; RE0070414. RX PUBMED: 20416281. RA Murakami Y., Hosoi F., Izumi H., Maruyama Y., Ureshino H., Watari K., Kohno K., Kuwano M., Ono M. RT Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells. RL Biochem. Biophys. Res. Commun. 396:376-381 (2010). RN [117]; RE0070421. RX PUBMED: 21135123. RA Sarkar S., Han J., Sinsimer K. S., Liao B., Foster R. L., Brewer G., Pestka S. RT RNA-binding protein AUF1 regulates lipopolysaccharide-induced IL10 expression by activating IkappaB kinase complex in monocytes. RL Mol. Cell. Biol. 31:602-615 (2011). RN [118]; RE0070443. RX PUBMED: 21479189. RA Carvalho G., Poalas K., Demian C., Hatchi E., Vazquez A., Bidere N. RT Participation of the cell polarity protein PALS1 to T-cell receptor-mediated NF-kappaB activation. RL PLoS ONE 6:e18159 (2011). RN [119]; RE0070741. RX PUBMED: 16356856. RA Matsumoto R., Wang D., Blonska M., Li H., Kobayashi M., Pappu B., Chen Y., Wang D., Lin X. RT Phosphorylation of CARMA1 plays a critical role in T Cell receptor-mediated NF-kappaB activation. RL Immunity 23:575-585 (2005). RN [120]; RE0070804. RX PUBMED: 21098220. RA Lou X., Sun S., Chen W., Zhou Y., Huang Y., Liu X., Shan Y., Wang C. RT Negative feedback regulation of NF-kappaB action by CITED2 in the nucleus. RL J. Immunol. 186:539-548 (2011). RN [121]; RE0070896. RX PUBMED: 20876301. RA Lai Y. J., Lin V. T., Zheng Y., Benveniste E. N., Lin F. T. RT The adaptor protein TRIP6 antagonizes Fas-induced apoptosis but promotes its effect on cell migration. RL Mol. Cell. Biol. 30:5582-5596 (2010). RN [122]; RE0071159. RX PUBMED: 19223432. RA Shinohara H., Yamasaki S., Maeda S., Saito T., Kurosaki T. RT Regulation of NF-kappaB-dependent T cell activation and development by MEKK3. RL Int. Immunol. 21:393-401 (2009). RN [123]; RE0071259. RX PUBMED: 21949020. RA Burns J. C., Corbo E., Degen J., Gohil M., Anterasian C., Schraven B., Koretzky G. A., Kliche S., Jordan M. S. RT The SLP-76 Src Homology 2 Domain Is Required for T Cell Development and Activation. RL J. Immunol. 187:4459-4466 (2011). RN [124]; RE0071528. RX PUBMED: 20410276. RA Yoboua F., Martel A., Duval A., Mukawera E., Grandvaux N. RT Respiratory syncytial virus-mediated NF-kappa B p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKK beta. RL J. Virol. 84:7267-7277 (2010). RN [125]; RE0071992. RX PUBMED: 19265123. RA Dai P., Jeong S. Y., Yu Y., Leng T., Wu W., Xie L., Chen X. RT Modulation of TLR signaling by multiple MyD88-interacting partners including leucine-rich repeat Fli-I-interacting proteins. RL J. Immunol. 182:3450-3460 (2009). RN [126]; RE0072508. RX PUBMED: 19109186. RA Kumar A., Wu H., Collier-Hyams L. S., Kwon Y. M., Hanson J. M., Neish A. S. RT The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation. RL J. Immunol. 182:538-546 (2009). XX //